About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Massachusetts | 601 Studies

Clinical Trials LymphomaMassachusetts

Lymphoma Clinical Trials in Massachusetts

Find 601 clinical trials for lymphoma near Massachusetts. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 601 trials

CompletedA Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell LymphomaThe purpose of this study is to evaluate the activity of romidepsin in patients with progressive or relapsed peripheral T-cell lymphoma (PTCL) who have already been treated with…NCT00426764·La Jolla, California and 89 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedProcurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical TrialsIn order to learn more about follicular lymphoma and anti-cancer vaccines, we are collecting samples from people with this diagnosis.NCT00487513·Boston, Massachusetts

CompletedA Study for Participants With Relapsed Cutaneous T-Cell LymphomaThe purpose of the study is to determine the efficacy and safety of enzastaurin in participants with Cutaneous T-Cell Lymphoma (CTCL) who failed prior therapies.NCT00744991·Birmingham, Alabama and 15 others

TerminatedStudy of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological MalignanciesThis is a phase I/II, non randomized, open-label, dose escalation study to investigate the safety, tolerability and preliminary efficacy of CB-103.NCT03422679·Santa Monica, California and 16 others

CompletedA Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin LymphomaThis study will evaluate the safety, pharmacokinetics, and preliminary efficacy of mosunetuzumab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone…NCT03677141·Birmingham, Alabama and 40 others

TerminatedPhase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's LymphomaThe objectives of this study are to evaluate the efficacy and safety of the Zevalin regimen compared to Zevalin and motexafin gadolinium in patients with rituximab-refractory…NCT01549886·Berkeley, California and 8 others

CompletedPhase II Study of Campath-1H Antibody to Treat Waldenstrom's MacroglobulinemiaThe purpose of this study is to determine the safety and effects (good or bad) of Campath-1H antibody in the treatment of lymphoplasmacytic lymphoma.NCT00142181·Boston, Massachusetts and 2 others

Active not recruitingEvaluation of Bariatric Endoscopic Antral Myotomy (BEAM) as a Treatment for ObesityIn the proposed study, we will be evaluating the effects of pylorus sparing antral myotomy alone, without concomitant endoscopic sleeve gastroplasty (ESG), on weight loss for…NCT05713071·Boston, Massachusetts

CompletedPhase 2 Study of Oral IXAZOMIB in Adult Participants With Relapsed and/or Refractory Follicular LymphomaThe primary purpose of this study is to evaluate the anti-tumor activity of oral Ixazomib as measured by overall response rate (ORR) in adult participants with relapsed and/or…NCT01939899·Boston, Massachusetts and 13 others

CompletedFludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or LymphomaRATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophosphamide, before a donor peripheral blood stem cell transplant helps stop the growth of cancer cells.NCT00006252·La Jolla, California and 18 others

CompletedComparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.NCT00059839·Birmingham, Alabama and 158 others

RecruitingA Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma PatientsThis is a global, randomised, Phase III, multicentre, open-label study evaluating the efficacy, safety and the degree of added benefit of the Surovatamig (AZD0486) plus rituximab…NCT06549595·Huntsville, Alabama and 234 others

Active not recruitingBlinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaThis randomized phase III trial studies how well blinatumomab works compared with standard combination chemotherapy in treating patients with B-cell acute lymphoblastic leukemia…NCT02101853·Birmingham, Alabama and 185 others

CompletedStudy of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell LymphomaThe goal of this clinical study is to assess whether axicabtagene ciloleucel therapy improves the clinical outcome compared with standard of care second-line therapy in…NCT03391466·Gilbert, Arizona and 71 others

CompletedIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerThis phase I trial is studying how well ipilimumab works after allogeneic stem cell transplant in treating patients with persistent or progressive cancer.NCT00060372·La Jolla, California and 4 others

CompletedEverolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell LymphomaEverolimus is an oral mTOR inhibitor with demonstrated preliminary efficacy and safety in diffuse large B-cell lymphoma (DLBCL) in both preclinical and clinical studies.NCT00869999·Boston, Massachusetts and 1 other

CompletedPRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily EnzastaurinThis clinical research study is to investigate the prevention of relapse in patients with diffuse large B cell lymphoma (DLBCL) using enzastaurin daily.NCT00332202·Anchorage, Alaska and 152 others

Active not recruitingRituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell LymphomaMantle cell lymphoma (MCL) is not curable with conventional therapy.NCT01661881·Boston, Massachusetts

TerminatedVaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells.NCT00089115·Birmingham, Alabama and 59 others

CompletedChemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00020943·Anniston, Alabama and 80 others

PreviousPage 8 of 31Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia